Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
4.950
-0.050 (-1.00%)
Jul 28, 2026, 10:18 AM EST
Veradigm Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue Revenue Growth | 594.41 | 594.41 | 625.98 | 588.02 | 577.43 | 556.12 |
Revenue Growth | -60.94% | -5.04% | 6.46% | 1.83% | 3.83% | -65.94% |
Gross Profit Gross Profit Growth | 302.25 | 302.25 | 341.51 | 308.42 | 282.45 | 264.23 |
Operating Income Operating Income Growth | -86.44 | -86.44 | 34.85 | -19.55 | 77.3 | 18.11 |
Net Income Net Income Growth | -291.54 | -291.54 | 49.18 | -86.46 | 139.57 | 696.05 |
Earnings Per Share EPS Growth | -2.70 | -2.70 | 0.41 | -0.77 | 1.01 | 4.37 |
EPS Growth | - | - | - | - | -77.00% | - |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Provider Provider Growth | 473.07 | 473.07 | 492.09 | 465.93 |
Payer Payer Growth | 67.31 | 67.31 | 72.28 | 56.21 |
Life Science Life Science Growth | 54.04 | 54.04 | 61.61 | 65.88 |
Total Total Growth | 594.41 | 594.41 | 625.98 | 588.02 |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Investments Cash & Investments Growth | 294.25 | 294.25 | 446.6 | 446.59 | 133.66 | 531.1 |
Total Debt Total Debt Growth | 239.51 | 239.51 | 217.51 | 219.44 | 372.95 | 283.31 |
Net Cash (Debt) Net Cash Growth | 54.74 | 54.74 | 229.09 | 227.15 | -239.29 | 247.79 |
Net Cash Growth | -80.47% | -76.10% | 0.85% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.51 | 0.51 | 1.84 | 2.03 | -1.73 | 1.56 |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Cash Flow Operating Cash Flow Growth | -20.03 | -20.03 | 99.51 | 116.82 | -76.62 | -103.66 |
Capital Expenditures CapEx Growth | -1.55 | -1.55 | -2.18 | -2.06 | -1.89 | -4.17 |
Free Cash Flow Free Cash Flow Growth | -21.58 | -21.58 | 97.33 | 114.76 | -78.51 | -107.82 |
Free Cash Flow Growth | - | - | -15.19% | - | - | - |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Gross Margin | 50.85% | 50.85% | 54.55% | 52.45% | 48.91% | 47.51% |
Operating Margin | -14.54% | -14.54% | 5.57% | -3.33% | 13.39% | 3.26% |
Pretax Margin | -37.36% | -37.36% | 9.56% | -10.86% | 27.31% | -2.26% |
Profit Margin | -49.05% | -49.05% | 7.86% | -14.70% | 24.17% | 125.16% |
FCF Margin | -3.63% | -3.63% | 15.55% | 19.52% | -13.60% | -19.39% |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
PE Ratio | - | - | 23.31 | - | 16.20 | 3.28 |
Forward PE | 21.02 | 10.36 | 12.58 | 20.47 | 19.33 | 21.14 |
P/FCF Ratio | - | - | 11.78 | 16.80 | - | - |
PS Ratio | 0.91 | 2.78 | 1.83 | 3.28 | 3.92 | 4.10 |